Scientists reveal mechanism behind mosquito-borne-disease 'blocker' used to fight viruses

June 15, 2017
This study found the introduction of Wolbachia bacteria (in purple) into insect cells, shown in the lower image, increased production of the gene Mt2, which reduced the ability of viruses (in blue) to reproduce. The new viruses produced were also less able to cause infection (shown as colorless viruses). Credit: Tamanash Bhattacharya

A new study from Indiana University may explain how a bacterium called Wolbachia prevents mosquitoes from transmitting deadly diseases such as dengue fever, West Nile virus and Zika.

Published today in the journal PLOS Pathogens, the study is one of the first to identify a specific biological mechanism that prevents mosquitoes infected with this bacterium from transmitting diseases to humans. It could also potentially open a path toward methods to block disease transmission without Wolbachia, an organism whose long-term effect on the environment is unknown.

"There's a real argument that some parts of the world are so strongly affected by these diseases that we need to try everything we can right away," said Irene Garcia Newton, assistant professor in the IU Bloomington College of Arts and Sciences' Department of Biology, who led the study. "But you've also got to remember that we're releasing insects into the wild that could potentially spread all over the planet very quickly, so it's important to move cautiously."

The use of Wolbachia-infected mosquitoes to curtail the spread of human diseases—a method called "pathogen blocking"—has already been implemented in some parts of the world. This includes the recent release of these mosquitoes in Florida to block the spread of Zika.

The spread of other insect-borne diseases is also expected to rise significantly in North America over the next several decades due to environmental change, according to the Centers for Disease Control and Prevention. Other viruses whose transmission is blocked in Wolbachia-infected mosquitoes include chikungunya, yellow fever and West Nile.

To explore the biological mechanisms behind pathogen blocking, Newton and colleagues designed a model system consisting of Wolbachia-infected and the Sindbis virus, which is easier—and safer—to manipulate in the lab than infectious agents such as the Zika or West Nile viruses.

"We've got a lot of genetic tools for Sindbis virus and fruit flies," said Richard Hardy, professor in the IU Bloomington Department of Biology, who is a co-author on the study. "This means we're able to label different parts of the virus genome and track replication of its RNA inside the host insect."

This illustration shows how the transmission of Wolbachia bacteria (in purple) from fruit flies to mosquitoes appears to block the transmission of viruses (in blue) to humans. Credit: Tamanash Bhattacharya

Based upon a comparison of Wolbachia-infected versus uninfected fruit flies, the scientists found that flies with the bacterium produced significantly higher levels of Mt2, a gene that encodes a type of enzyme known as a methyltransferase.

They then used genetic tools to create two types of fruit flies: one that lacked this enzyme and another that produced unusually high levels of it.

The flies without the enzyme lost their ability to "block" the transmission of the Sindbis virus after infection with Wolbachia. The flies that produced high levels of the enzyme were resistant to the Sindbis virus—even if they weren't infected with Wolbachia.

"The fact that flies with high expression levels of this enzyme were protected against virus infection despite the absence of Wolbachia is very significant," said Tamanash Bhattacharya, an IU Ph.D. student who is first author on the study. "These results suggest that the methyltransferase Mt2 alone is sufficient to create a virus protection effect."

Moreover, this protective effect likely applies to the transmission of other deadlier viruses, not only the Sindbis . The lack of genetic similarities between viruses blocked by Wolbachia suggests that the bacterium blocks viruses through effects on the host.

There are a number of reasons scientists are interested in pursuing methods of pathogen-blocking without Wolbachia, Newton added. The widespread release of Wolbachia-infected mosquitoes could potentially trigger the rise of viruses resistant to the bacteria, for example.

There is also a lack of large-scale epidemiological studies to scientifically determine whether pathogen-blocking actually prevents outbreaks.

"Right now, we know only that mosquitoes infected by Wolbachia don't transmit diseases—but we don't really know how," Newton said. "If we don't understand the biological mechanisms behind pathogen blocking, we can't really know what will happen over the long term when we release these ."

Explore further: Mosquitoes infected with virus-suppressing bacteria could help control dengue fever

More information: PLOS Pathogens (2017). DOI: 10.1371/journal.ppat.1006427

Related Stories

Mosquitoes infected with virus-suppressing bacteria could help control dengue fever

May 30, 2017
Mosquitos infected with the bacteria Wolbachia are significantly worse vectors for dengue virus, but how to establish and spread Wolbachia in an urban mosquito population is unclear. A study publishing on 30th May 2017 in ...

Control strategy for Dengue, malaria increases risk of West Nile virus

July 10, 2014
Mosquitoes infected with the bacteria Wolbachia are more likely to become infected with West Nile virus and more likely to transmit the virus to humans, according to a team of researchers.

Infecting mosquitoes with bacteria so they can't infect us with viruses like Zika and dengue

May 23, 2017
Mosquitoes and their itchy bites are more than just an annoyance. They transmit dangerous viruses with deadly consequences – making them the most lethal animal on Earth. It's the Aedes aegypti and Aedes albopictus mosquito ...

Inheritable bacterium controls Aedes mosquitoes' ability to transmit Zika

May 4, 2016
Aedes mosquitoes carrying the bacterium Wolbachia—found inside the cells of 60 percent of all insect species—are drastically less able to transmit Zika virus, say researchers at Brazil's Oswaldo Cruz Foundation (FIOCRUZ) ...

Virus-resistant mosquitoes to be unleashed in Colombia, Brazil

October 26, 2016
Governments and philanthropists on Wednesday announced an $18 million plan to release mosquitoes resistant to Zika, dengue and other viruses in urban areas of Colombia and Brazil.

Recommended for you

Zika virus stifles pregnant women's weakened immune system to harm baby, study finds

August 21, 2017
The Zika virus, linked to congenital birth defects and miscarriages, suppresses a pregnant woman's immune system, enabling the virus to spread and increasing the chances an unborn baby will be harmed, a Keck School of Medicine ...

Fatty liver can cause damage to other organs via crosstalk

August 21, 2017
Nonalcoholic fatty liver disease is increasingly common. Approximately every third adult in industrialized countries has a morbidly fatty liver. This not only increases the risk of chronic liver diseases such as liver cirrhosis ...

Faulty gene linked to obesity in adults

August 18, 2017
Groundbreaking new research linking obesity and metabolic dysfunction to a problem in the energy generators in cells has been published by researchers from the Harry Perkins Institute of Medical Research and The University ...

Two lung diseases killed 3.6 million in 2015: study

August 17, 2017
The two most common chronic lung diseases claimed 3.6 million lives worldwide in 2015, according to a tally published Thursday in The Lancet Respiratory Medicine.

New test differentiates between Lyme disease, similar illness

August 16, 2017
Lyme disease is the most commonly reported vector-borne illness in the United States. But it can be confused with similar conditions, including Southern Tick-Associated Rash Illness. A team of researchers led by Colorado ...

Addressing superbug resistance with phage therapy

August 16, 2017
International research involving a Monash biologist shows that bacteriophage therapy – a process whereby bacterial viruses attack and destroy specific strains of bacteria - can be used successfully to treat systemic, multidrug ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.